A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
Clinical trial NCT05152147 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05152147
- Sponsor
- Jazz Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-02
- Primary completion
- 2026-07-31
- Enrollment
- 920
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.